Remove 2001 Remove Clinical Trials Remove Safety
article thumbnail

UK: Tory MP Crispin Blunt At Loggerheads With The Home Office Over Psilocybin Research

Cannabis Law Report

A Home Office spokesperson said: “There is an established process for the development of medicines, which enables medicines including psilocybin to be developed, evaluated in clinical trials and licensed based on an assessment of their quality, safety and efficacy. Source: [link].

article thumbnail

New Study: Demographic and policy-based differences in behaviors and attitudes towards driving after marijuana use: an analysis of the 2013–2017 Traffic Safety Culture Index

Cannabis Law Report

The Traffic Safety Culture Index is an annual survey with national scope and multiple measures relevant to driving after marijuana use. Because THC presence is an imperfect proxy for impairment [ 10 ], driving data may be limited in clarifying what traffic safety risks, if any, are associated with permissive marijuana policies.

Policy 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer.

article thumbnail

Mixing weed and alcohol: the good, the bad and the ugly

The Cannigma

A clinical trial published in 2015 found that the test subjects had “significantly higher blood THC” levels when they used cannabis along with alcohol, and combining the two led to increased performance impairment. CBD and alcohol safety.

article thumbnail

Best strains and terpenes for migraine relief

The Cannigma

10 A 2001 review paper by cannabis researcher Dr. Ethan Russo details the historical use of cannabis for migraines. Russo concluded the evidence he examined “supports experimental protocols of cannabis usage in migraine treatment should go forward employing modern controlled clinical trials.”

Terpenes 135
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Only one article appeared in the MJA in 2000 and again in 2001. 24), and conveyed safety concerns ( n ?=?23).

article thumbnail

Guest Post: Denmark’s pilot pharma trial attracts first-movers

Cannabis Law Report

They are learning quickly from the successes and failures in Canada’s legal medical cannabis program that has been active since 2001. The roadmap ahead includes clinical trials and more research in Denmark. Hundreds of GPs have prescribed medical cannabis and thousands of patients have received prescriptions in Denmark.